Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,351 | -23,756 | -17,170 | -10,688 | -4,998 |
| Depreciation Amortization | 300 | 1,266 | 960 | 639 | 308 |
| Accounts receivable | 5 | 765 | 764 | -5 | 753 |
| Accounts payable and accrued liabilities | -1,220 | 1,385 | 973 | -33 | 10 |
| Other Working Capital | -758 | 1,839 | 1,761 | 999 | 922 |
| Other Operating Activity | -37 | 300 | 196 | 903 | -720 |
| Operating Cash Flow | $-6,061 | $-18,201 | $-12,516 | $-8,185 | $-3,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -179 | -7 | -7 | -6 |
| Investing Cash Flow | $0 | $-179 | $-7 | $-7 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | 10,000 | 10,000 | 5,000 |
| Debt Repayment | -208 | N/A | -636 | N/A | -233 |
| Common Stock Issued | 27,782 | 10,209 | 3,149 | 281 | N/A |
| Dividend Paid | N/A | -1,819 | -1,820 | -1,820 | -1,213 |
| Other Financing Activity | 0 | -1,757 | -100 | -469 | 0 |
| Financing Cash Flow | $27,574 | $16,633 | $10,593 | $7,992 | $3,554 |
| Exchange Rate Effect | -1 | 3 | 3 | 4 | 6 |
| Beginning Cash Position | 3,739 | 5,483 | 5,483 | 5,483 | 5,483 |
| End Cash Position | 25,251 | 3,739 | 3,556 | 5,287 | 5,312 |
| Net Cash Flow | $21,512 | $-1,744 | $-1,927 | $-196 | $-171 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,061 | -18,201 | -12,516 | -8,185 | -3,725 |
| Capital Expenditure | 0 | -179 | -7 | -7 | -6 |
| Free Cash Flow | -6,061 | -18,380 | -12,523 | -8,192 | -3,731 |